Amgen said it was pleased with the verdict and would seek an injunction to prevent Roche from releasing Mircera in the United States.
安进声称满意判决，并将寻求禁令以阻止罗氏在美国发布Mircera。
A federal judge has ruled that Mircera, a Roche anemia drug that would compete with Amgen's Epogen and Aranesp, violates an Amgen patent.
一次联邦审判认定Mircera，一个罗氏生产的用于同安进的Epogen和Aranesp竞争的药物，触犯了安进的专利权。
A jury in Federal District Court in Boston ruled that Roche's new drug, Mircera, infringed on three Amgen patents and upheld the validity of those patents and two others.
一个波士顿的联邦地区法庭陪审团判定罗氏的新药Mircera侵犯了三项安进公司专利，并且确定这些专利和其他两项专利的有效性。
A jury in Federal District Court in Boston ruled that Roche's new drug, Mircera, infringed on three Amgen patents and upheld the validity of those patents and two others.
一个波士顿的联邦地区法庭陪审团判定罗氏的新药Mircera侵犯了三项安进公司专利，并且确定这些专利和其他两项专利的有效性。
应用推荐